These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 749908)

  • 1. Studies on the use of mumps virus for treatment of human cancer.
    Okuno Y; Asada T; Yamanishi K; Otsuka T; Takahashi M; Tanioka T; Aoyama H; Fukui O; Matsumoto K; Uemura F; Wada A
    Biken J; 1978 Jun; 21(2):37-49. PubMed ID: 749908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of human cancer with mumps virus.
    Asada T
    Cancer; 1974 Dec; 34(6):1907-28. PubMed ID: 4611607
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell].
    Toh U; Yamana H; Kido K; Mine T; Fujii T; Horiuchi H; Sasatomi T; Ishibashi N; Yutani S; Fujita H; Shirouzu K
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1566-70. PubMed ID: 14619465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy of cancer. Experiments in the modification of tumor antigenicity].
    Mizukami T; Takamura Y
    Arch Geschwulstforsch; 1971; 37(1):33-44. PubMed ID: 4102699
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of advanced gynecologic cancer patients utilizing mumps virus.
    Shimizu Y; Hasumi K; Okudaira Y; Yamanishi K; Takahashi M
    Cancer Detect Prev; 1988; 12(1-6):487-95. PubMed ID: 2972361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.
    Richards J; Auger J; Peace D; Gale D; Michel J; Koons A; Haverty T; Zivin R; Jolliffe L; Bluestone JA
    Cancer Res; 1999 May; 59(9):2096-101. PubMed ID: 10232594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Tribromomethane (Bromoform) (CAS No. 75-25-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 May; 350():1-194. PubMed ID: 12704434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin.
    Kontani K; Taguchi O; Ozaki Y; Hanaoka J; Sawai S; Inoue S; Abe H; Hanasawa K; Fujino S
    Int J Mol Med; 2003 Oct; 12(4):493-502. PubMed ID: 12964025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.
    Lotze MT; Frana LW; Sharrow SO; Robb RJ; Rosenberg SA
    J Immunol; 1985 Jan; 134(1):157-66. PubMed ID: 3871099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of the combined use of radiation therapy and hyperthermia].
    Matsuda T; Tanaka Y; Takeshita N; Ishiwata J; Awane Y
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1508-14. PubMed ID: 3592696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection.
    Karanikas V; Thynne G; Mitchell P; Ong CS; Gunawardana D; Blum R; Pearson J; Lodding J; Pietersz G; Broadbent R; Tait B; McKenzie IF
    J Immunother; 2001; 24(2):172-83. PubMed ID: 11265775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adoptive immunotherapy of cancer patients with lymphokine-activated killer cells].
    Taguchi T; Domoto K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):914-21. PubMed ID: 3494428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors.
    Dummer R; Bergh J; Karlsson Y; Horowitz JA; Mulder NH; Huinink DTB ; Burg G; Hofbauer G; Osanto S
    Cancer Gene Ther; 2000 Jul; 7(7):1069-76. PubMed ID: 10917210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic and clinical study of adoptive immunotherapy using cytotoxic T lymphocyte (CTL) against cancers].
    Kitsukawa K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1448-54. PubMed ID: 2543306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
    Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.